Emergent Biosolutions Inc (EBS) — Working Capital to Net Assets Ratio
Emergent Biosolutions Inc (EBS) has a Working Capital to Net Assets ratio of 159.1% as of June 2026. Working capital of $543.20 Million (current assets of $666.00 Million minus current liabilities of $122.80 Million) is measured against net assets of $341.40 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See EBS days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Emergent Biosolutions Inc Working Capital to Net Assets (2001–2025)
This chart shows how Emergent Biosolutions Inc's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2001 to 2025. As of June 2026, the ratio stands at 159.1%, reflecting working capital of $543.20 Million against net assets of $341.40 Million USD. For the complete balance sheet picture, see how large is Emergent Biosolutions Inc's balance sheet.
Annual Working Capital to Net Assets for Emergent Biosolutions Inc (2001–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Emergent Biosolutions Inc from 2001 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Emergent Biosolutions Inc (EBS) asset resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 101.5% | $530.30 Million | $522.60 Million | $662.50 Million | $132.20 Million | ▲ +11.1 pp |
| 2024 | 90.4% | $436.30 Million | $482.80 Million | $598.70 Million | $162.40 Million | ▲ +86.0 pp |
| 2023 | 4.3% | $28.20 Million | $649.30 Million | $679.50 Million | $651.30 Million | ▲ +5.7 pp |
| 2022 | -1.3% | $-18.50 Million | $1.39 Billion | $1.21 Billion | $1.23 Billion | ▼ -56.9 pp |
| 2021 | 55.6% | $895.90 Million | $1.61 Billion | $1.27 Billion | $374.00 Million | ▼ -0.5 pp |
| 2020 | 56.1% | $811.40 Million | $1.45 Billion | $1.20 Billion | $384.50 Million | ▲ +12.9 pp |
| 2019 | 43.2% | $469.90 Million | $1.09 Billion | $686.20 Million | $216.30 Million | ▲ +1.6 pp |
| 2018 | 41.6% | $420.40 Million | $1.01 Billion | $620.80 Million | $200.40 Million | ▼ -0.6 pp |
| 2017 | 42.2% | $385.32 Million | $912.35 Million | $485.39 Million | $100.07 Million | ▼ -25.6 pp |
| 2016 | 67.8% | $404.36 Million | $596.21 Million | $510.22 Million | $105.86 Million | ▲ +1.3 pp |
| 2015 | 66.5% | $439.00 Million | $660.02 Million | $538.61 Million | $99.61 Million | ▲ +5.2 pp |
| 2014 | 61.3% | $339.24 Million | $553.20 Million | $432.18 Million | $92.94 Million | ▲ +17.1 pp |
| 2013 | 44.3% | $216.46 Million | $489.17 Million | $273.12 Million | $56.65 Million | ▼ -1.3 pp |
| 2012 | 45.6% | $201.44 Million | $442.13 Million | $263.35 Million | $61.91 Million | ▲ +1.6 pp |
| 2011 | 44.0% | $183.36 Million | $416.73 Million | $254.42 Million | $71.05 Million | ▼ -0.9 pp |
| 2010 | 44.9% | $167.77 Million | $373.56 Million | $243.49 Million | $75.72 Million | ▼ -12.1 pp |
| 2009 | 57.1% | $139.11 Million | $243.81 Million | $193.81 Million | $54.70 Million | ▲ +7.6 pp |
| 2008 | 49.5% | $98.66 Million | $199.35 Million | $152.68 Million | $54.02 Million | ▼ -2.3 pp |
| 2007 | 51.8% | $88.65 Million | $171.16 Million | $144.31 Million | $55.66 Million | ▼ -8.1 pp |
| 2006 | 59.9% | $82.99 Million | $138.47 Million | $147.34 Million | $64.35 Million | ▲ +11.3 pp |
| 2005 | 48.6% | $29.02 Million | $59.74 Million | $59.12 Million | $30.09 Million | ▲ +15.9 pp |
| 2004 | 32.7% | $7.51 Million | $22.95 Million | $41.70 Million | $34.19 Million | ▲ +2545.2 pp |
| 2001 | -2512.5% | $811.40 Million | $-32.30 Million | $1.20 Billion | $384.50 Million | — |